Standard BioTools's market cap is currently $496.59M. The company's EPS TTM is $-0.05; its P/E ratio is ―; Standard BioTools is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
